InvestorsHub Logo
Followers 0
Posts 148
Boards Moderated 0
Alias Born 04/12/2007

Re: LOCHUTE post# 177973

Tuesday, 04/08/2008 8:50:05 PM

Tuesday, April 08, 2008 8:50:05 PM

Post# of 203990
Just received this in an e-mail. Can't say who it's from, so take it for what it's worth - to you. It is genuine:

NHLBI is still supporting research on 5HMF (5-hydroxymethyl furfural) as a potential antisickling agent for sickle cell disease, both through a small business grant to Xechem, Inc in New Jersey, and through the NIH RAID drug development program. I would say there is still some promise here, and the final word on this drug is not yet in.

While NHLBI does not support research on the natural product niprisan to the best of my knowledge, my understanding is that Xechem believes this is a beneficial drug and is marketing it for sickle cell disease in Africa. I refer you to Xechem for further information.


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.